Innovent Biologics, Inc. (HKG:1801)
Hong Kong
· Delayed Price · Currency is HKD 84.90
+2.30 (2.78%)
Apr 29, 2026, 4:08 PM HKT
Innovent Biologics Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 17,345 | 7,508 | 10,052 | 9,163 | 8,377 | Upgrade
|
| Short-Term Investments | 886.74 | 375.56 | 867.53 | - | - | Upgrade
|
| Trading Asset Securities | - | - | 50 | 3.21 | 638.21 | Upgrade
|
| Cash & Short-Term Investments | 18,231 | 7,884 | 10,970 | 9,166 | 9,015 | Upgrade
|
| Cash Growth | 131.25% | -28.13% | 19.68% | 1.67% | 11.01% | Upgrade
|
| Accounts Receivable | 1,714 | 1,184 | 1,006 | 575.27 | 968.41 | Upgrade
|
| Receivables | 1,714 | 1,184 | 1,006 | 575.27 | 975.91 | Upgrade
|
| Inventory | 1,302 | 822.17 | 968.09 | 1,429 | 1,347 | Upgrade
|
| Other Current Assets | 766.31 | 382.52 | 484.38 | 336.52 | 212.4 | Upgrade
|
| Total Current Assets | 22,013 | 10,273 | 13,428 | 11,507 | 11,551 | Upgrade
|
| Property, Plant & Equipment | 5,441 | 5,647 | 4,656 | 3,826 | 3,090 | Upgrade
|
| Long-Term Investments | 7,860 | 3,901 | 794.09 | 630.2 | 417.26 | Upgrade
|
| Other Intangible Assets | 1,534 | 307.48 | 27.79 | 30.05 | 19.75 | Upgrade
|
| Long-Term Deferred Charges | 99.82 | 975.12 | 1,242 | 1,168 | 752.45 | Upgrade
|
| Other Long-Term Assets | 399.11 | 499.02 | 478.64 | 427.63 | 412.07 | Upgrade
|
| Total Assets | 37,348 | 21,603 | 20,627 | 17,589 | 16,244 | Upgrade
|
| Accounts Payable | 494.59 | 357.68 | 372.55 | 325.62 | 195.05 | Upgrade
|
| Accrued Expenses | - | 2,739 | 1,962 | 1,517 | 1,678 | Upgrade
|
| Current Portion of Long-Term Debt | 789.17 | 405.1 | 1,195 | 888 | 365 | Upgrade
|
| Current Portion of Leases | 11.03 | 8.83 | 25.18 | 26.39 | 22.27 | Upgrade
|
| Current Income Taxes Payable | - | 75.84 | 194.05 | 3.3 | 60.59 | Upgrade
|
| Current Unearned Revenue | 2,312 | 256.41 | 416.17 | 434.91 | 355.51 | Upgrade
|
| Other Current Liabilities | 4,780 | 525.53 | 312.16 | 303.71 | 374.05 | Upgrade
|
| Total Current Liabilities | 8,387 | 4,369 | 4,477 | 3,499 | 3,050 | Upgrade
|
| Long-Term Debt | 1,990 | 2,412 | 2,327 | 2,215 | 2,023 | Upgrade
|
| Long-Term Leases | 25.98 | 4.76 | 73.42 | 98.68 | 86.39 | Upgrade
|
| Long-Term Unearned Revenue | 6,946 | 1,215 | 960.05 | 883.28 | 753.27 | Upgrade
|
| Other Long-Term Liabilities | 643.01 | 483.82 | 262.71 | 162.31 | 0.34 | Upgrade
|
| Total Liabilities | 17,992 | 8,485 | 8,100 | 6,859 | 5,913 | Upgrade
|
| Common Stock | 0.12 | 0.11 | 0.11 | 0.11 | 0.1 | Upgrade
|
| Additional Paid-In Capital | - | 27,723 | 27,324 | 24,706 | 22,494 | Upgrade
|
| Retained Earnings | - | -15,906 | -15,768 | -14,740 | -12,560 | Upgrade
|
| Comprehensive Income & Other | 19,356 | 1,301 | 970.54 | 763.86 | 397.02 | Upgrade
|
| Total Common Equity | 19,356 | 13,118 | 12,528 | 10,730 | 10,330 | Upgrade
|
| Shareholders' Equity | 19,356 | 13,118 | 12,528 | 10,730 | 10,330 | Upgrade
|
| Total Liabilities & Equity | 37,348 | 21,603 | 20,627 | 17,589 | 16,244 | Upgrade
|
| Total Debt | 2,816 | 2,831 | 3,621 | 3,229 | 2,497 | Upgrade
|
| Net Cash (Debt) | 15,416 | 5,053 | 7,349 | 5,938 | 6,518 | Upgrade
|
| Net Cash Growth | 205.10% | -31.25% | 23.77% | -8.91% | -5.73% | Upgrade
|
| Net Cash Per Share | 8.85 | 3.10 | 4.71 | 3.98 | 4.48 | Upgrade
|
| Filing Date Shares Outstanding | 1,712 | 1,638 | 1,622 | 1,534 | 1,462 | Upgrade
|
| Total Common Shares Outstanding | 1,712 | 1,638 | 1,622 | 1,534 | 1,462 | Upgrade
|
| Working Capital | 13,627 | 5,904 | 8,951 | 8,008 | 8,501 | Upgrade
|
| Book Value Per Share | 11.31 | 8.01 | 7.72 | 6.99 | 7.07 | Upgrade
|
| Tangible Book Value | 17,822 | 12,810 | 12,500 | 10,700 | 10,311 | Upgrade
|
| Tangible Book Value Per Share | 10.41 | 7.82 | 7.71 | 6.97 | 7.05 | Upgrade
|
| Buildings | - | 1,702 | 402.67 | 402.46 | 389.73 | Upgrade
|
| Machinery | - | 3,133 | 4,795 | 2,523 | 1,420 | Upgrade
|
| Construction In Progress | - | 1,339 | 6.18 | 1,139 | 1,293 | Upgrade
|
| Leasehold Improvements | - | 426.63 | 121.82 | 107.66 | 106.85 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.